Facts
- HQ
- United States
- Sectors
- Venture Capital
- Last fund
- Quiet Fund II Warehouse LLC · $82.1M · 2021 SEC Form D
- Funds raised
- 3 funds SEC Form D filings
- Total capital
- $560.9M SEC Form D filings
BuyWander moves HQ from Spokane to Kent, Seattle area; grows to 325 employees and adds four executives
BuyWander, a retail-returns auction marketplace founded in Spokane in 2023, moved its headquarters to Kent in the Seattle area, expanded to 325 employees, added four executives (including two former Amazon leaders), and is growing its national warehouse network and market presence.
Intropy raises $11 million seed round to build AI-native operating system for spare parts; led by Felix Capital
Intropy, an AI-native platform for automating inventory, pricing and other decisions in the spare parts supply chain, announced a $11 million seed funding round led by Felix Capital with participation from Quiet Capital, General Catalyst and firstminute capital. The company was founded in 2024 by Franziska Kirschner and YihKai Teh.
AlleyWatch lists 19 Biggest Global Startup Funding Rounds of July 2026, including a ¥50B Chinese AI raise and $1.4B German robotics deal
An AlleyWatch roundup, using CrunchBase data, lists the largest global startup funding rounds in July 2026, highlighting major multi‑hundred‑million and billion‑dollar investments across AI, robotics, nuclear fusion, quantum computing, and military AI.
Seattle Startup Diagrid Raises $20M Series A Led by Norwest, Backed by Microsoft Azure CTO and Kubernetes Co-founder
Seattle startup Diagrid, co-founded by former Microsoft engineers who created the Dapr project, raised $20 million in a Series A led by Norwest Venture Partners to provide managed Dapr on Kubernetes services. The company’s software supports cloud-native applications and has backing from prominent industry figures including Microsoft Azure CTO Mark Russinovich and Kubernetes co-founder Joe Beda.
Cyrus Biotechnology raises $18M and acquires Orthogonal Biologics, adding COVID-19 decoy therapeutic and deep mutational scanning platform
Seattle protein engineering company Cyrus Biotechnology raised $18 million and acquired Orthogonal Biologics, adding a deep mutational scanning platform and two protein therapeutics including a potential COVID-19 decoy. Cyrus leverages University of Washington IPD tools (Rosetta, RoseTTAfold) and has partnerships including a deal with Selecta Biosciences worth up to $1.5 billion.
